Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyChristine E. Brown, Behnam Badie, Michael C. Jensen et al.|New England Journal of Medicine|2016Cited by 1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent GlioblastomaChristine E. Brown, Michael C. Jensen, Behnam Badie et al.|Clinical Cancer Research|2015Cited by 754
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory PhenotypeDarya Alizadeh, Christine E. Brown, Robyn A. Wong et al.|Cancer Immunology Research|2019Cited by 437
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemiaArmen Mardiros, Stephen J. Forman, Cédric Dos Santos et al.|Blood|2013Cited by 373
Specific Recognition and Killing of Glioblastoma Multiforme by Interleukin 13-Zetakine Redirected Cytolytic T CellsKanwarpal Kahlon, Michael C. Jensen, Christine E. Brown et al.|Cancer Research|2004Cited by 367